Boris Duchemann

18PUBLICATIONS
65CO-AUTHORS
Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Tumour immunologyCancer therapy (excl. chemotherapy and radiation therapy)Computational neuroscience (incl. mathematical neuroscience and theoretical neuroscience)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Jul 11, 2026
End-of-life management and causes of death in ALK-positive non-small cell lung cancer in France: a multicentric analysis.

|Dec 15, 2025
Timing of Immunotherapy in Practice: Feasibility and Impact of Morning Checkpoint Inhibitor Administration.

Pasquale F Innominato, Thierry Landré, Abdoulaye Karaboué

|Jul 02, 2025
Regulatory T Cells Poise the Myeloid Landscape after Chemotherapy in Lung Tumors.

Eléonore Weber-Delacroix, Marylou Panouillot, Marie Laviron

|Nov 13, 2024
The CheckMate 816 trial: a milestone in neoadjuvant chemoimmunotherapy of nonsmall cell lung cancer.

Marie Mayenga, Ana Rita Pedroso, Marion Ferreira

|Nov 08, 2023
Human virome profiling identified CMV as the major viral driver of a high accumulation of senescent CD8+ T cells in patients with advanced NSCLC.

Marie Naigeon, Matthieu Roulleaux Dugage, François-Xavier Danlos

|Sep 18, 2023
Holistic management of patients with progressive pulmonary fibrosis.

Ana Oliveira, Gaia Fabbri, Thomas Gille

Pageof 3

Frequent Collaborators

3 joint publications

Christos Chouaid

3 joint publications

Aurelien Marabelle

3 joint publications

Nathalie Chaput

2 joint publications

Ilaria Onorati